News | RSNA | December 01, 2020

Mary C. Mahoney, MD, Named RSNA President

Mary C. Mahoney, M.D.

Mary C. Mahoney, M.D.

December 1, 2020 — At the Virtual RSNA 2020 conference, it was announced that Mary C. Mahoney, M.D., is RSNA president for 2021. An internationally recognized authority on breast imaging and mammography and a staunch advocate of patient-centered radiology, Mahoney is the Benjamin Felson Endowed Chair and Professor of Radiology at the University of Cincinnati (UC) College of Medicine in Cincinnati, Ohio. Since 2016, Mahoney has been chief of imaging services at UC Health in Cincinnati and is on the medical staff of several Cincinnati area institutions, including UC Medical Center, University Pointe Surgical Hospital, and West Chester Hospital in West Chester, Ohio.

As president, Mahoney will continue to focus on patient-centered care and support the Society’s goal of fostering diversity, equity and inclusion in radiology leadership and practice.

“I am honored to be part of an organization that actively supports women in radiology and works to promote diversity and inclusivity in its leadership, in its committees and in its programming,” Mahoney said. “We must ensure that our academic and society leaders reflect the diverse community we represent and strive to provide an equitable and inclusive community that serves the needs of all of our members. In shedding unconscious bias and embracing different perspectives, we strengthen our specialty and enhance the quality of care we provide to our patients.”

After graduating magna cum laude from Brown University, Mahoney received her medical degree from UC College of Medicine, and is a member of its honor society, Alpha Omega Alpha. She completed her diagnostic radiology residency — serving as chief resident followed by a fellowship — at UC Medical Center.

Over the years, Mahoney has served RSNA in many capacities. She was the scientific session presiding officer from 2003 to 2009. She has served on many committees, including the R&E Foundation Public Relations Committee and the Public Information Advisors Network. She has chaired the Public Information Committee, Patient-Centered Radiology Steering Committee and the Radiology Editor Search Committee. She joined the RSNA Board in 2014.

A respected leader in the field, Mahoney has held committee or leadership positions in a number of other organizations, including the Society of Breast Imaging (SBI) and the American Roentgen Ray Society. She served on the ABR Board of Trustees from 2010 to 2015 and the ABR Board of Governors from 2015 to 2018 and currently serves on the American College of Radiology (ACR) Board of Chancellors. Mahoney is a fellow of both ACR and SBI and is a member of the Society of Chairs of Academic Radiology Departments.

Mahoney has published more than 90 peer-reviewed articles and 15 book chapters and has co-authored two books with an emphasis on breast imaging. She has served as principal or co-investigator on numerous funded grants, including several grants focused on imaging modalities and biopsy. Mahoney has given many scientific research presentations nationally and internationally and has been an invited lecturer at over 285 institutions and meetings worldwide.

She is a graduate of the Executive Leadership in Academic Medicine program for women leaders in medicine. She has been instrumental in building the Advanced Imaging Core Lab at UC College of Medicine and the multidisciplinary breast center within UC Cancer Institute.

Since 2002, Mahoney has been a manuscript reviewer for Radiology. She is currently on the editorial boards of Cureus and Contemporary Diagnostic Radiology and the editorial advisory board of Radiology Business Journal. Since 2005, Mahoney has been a Self-Assessment Module reviewer for the American Board of Radiology (ABR).

The recipient of many awards and honors throughout her career, Mahoney was recognized by ABR for her extraordinary service and dedication in 2008 and 2010. She was named a Health Care Hero finalist twice by the Cincinnati Business Courier and received a Marquis Who’s Who Lifetime Award in 2017. She was included on the “Best Doctors in Cincinnati” list, selected for inclusion in Top Doctors in America in 2019 and selected for “Top Doctors” by Cincinnati Magazine in 2020.

Haffty is RSNA President-Elect

Bruce G. Haffty, M.D., is RSNA president-elect for 2021. Haffty is associate vice chancellor, Cancer Programs, at Rutgers Biomedical and Health Sciences. He also serves as professor and chairman in the Department of Radiation Oncology at Rutgers Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School.

As president-elect, Haffty will work to maintain strong governance of the Society and raise the profile of RSNA and radiology outside of the radiology community.

“The RSNA Board of Directors has held a number of valuable and extensive discussions concerning the governance of our organization,” Haffty said. “I look forward to continuing those discussions and determining the optimal governance structure moving forward for RSNA. In addition, the Board plans to explore collaborations with other organizations that will be beneficial for our Society and our specialty.”

Haffty’s extensive service to RSNA includes serving as third vice president and as co-chair of the Bolstering Oncoradiologic and Oncoradiotherapeutic Skills for Tomorrow (BOOST) Program. At RSNA 2009, he delivered the Annual Oration in Radiation Oncology. Haffty was named RSNA Outstanding Educator in 2013. Haffty has been on the RSNA Board of Directors since 2014, serving as liaison for science and chair. He also served on the RSNA News editorial board.

Haffty completed his medical school and residency training at Yale University School of Medicine and spent the next 18 years specializing in breast, head and neck cancers in Yale’s Department of Therapeutic Radiology. He served on the faculty at Yale from 1988 through 2005. Haffty was promoted to professor of therapeutic radiology, served as residency program director from 1992 through 2004, and vice chairman and clinical director from 2002 to 2005.

Haffty’s research on new methods of delivering radiation therapy for breast cancer has focused on molecular and genetic factors as they relate to radiation resistance and outcomes in patients. Dr. Haffty is a leader in national clinical trials and is currently co-investigator on several national clinical trials through the NRG Oncology and Alliance for Clinical Trials in Oncology cooperative groups.

At Rutgers Robert Wood Johnson Medical School, New Jersey Medical School and Cancer Institute of New Jersey — now part of Rutgers, Haffty spearheaded the expansion of the Radiation Oncology Program and developed residency programs in radiation oncology and medical physics — the only such programs in the state of New Jersey.

Haffty has authored or co-authored 50 books, book chapters and theses, more than 400 peer-reviewed articles and numerous editorials and letters. In addition to editing the comprehensive Handbook of Radiation Oncology, Haffty has served on numerous editorial boards. He currently serves on the editorial board of The Breast Journal and serves as deputy editor of Journal of Clinical Oncology.

Through his extensive work with the American Society for Radiation Oncology, Haffty served as the founding president of the Association of Directors of Radiation Oncology Programs in 2000. Haffty is a past president of the American Radium Society, past chairman of the Residency Review Committee in Radiation Oncology, past president of the American Board of Radiology and past president of American Society for Radiation Oncology.

For more information: www.rsna.org

Related Content

News | Breast Imaging | September 20, 2021
September 20, 2021 — ImageCare Centers is unveiling its new “PINK Better Mammo” service with the addition of...
IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.
News | Radiation Oncology | September 17, 2021
September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, a
Shimadzu Medical Systems USA, a leading manufacturer of advanced medical X-ray imaging systems, has announced that the Trinias unity edition product line has been awarded a contract from Vizient, Inc., a healthcare performance improvement company, effective Sept. 1, 2021.
News | X-Ray | September 17, 2021
September 17, 2021 — Shimadzu Medical Systems USA, a leading manufacturer of advanced medical...
Avoiding contrast dyes for imaging tests not necessary if concerned about iodine allergy, peer-reviewed study concludes #MRI

Getty Images

News | Contrast Media Injectors | September 16, 2021
September 16, 2021 — FDB (First Databank), a leading provider of drug and medical device knowledge that helps healthc
This is an example of 3-D ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

This is an example of TriVu ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

Feature | Breast Imaging | September 15, 2021 | By Jennifer Meade
The...
While the Mammography Quality Standards Act (MQSA) and the introduction of EQUIP (Enhancing Quality Using the Inspection Program) have been successful in standardizing and enhancing mammographic imaging quality, inadequate breast positioning can dramatically impact the ability of radiologists and technicians to quickly and accurately detect breast cancer and potentially malignant lesions in their patients

Getty Images

Feature | Mammography | September 15, 2021 | By Christopher Austin, M.D. and Randy D. Hicks, M.D., MBA
Revised guidelines for lung cancer screening eligibility are perpetuating disparities for racial/ethnic minorities, according to a new study in Radiology.

Getty Images

News | Lung Imaging | September 15, 2021
September 15, 2021 — Revised guidelines for...
Revenues for teleradiology reading service providers are forecast to follow a similar profile over this period.

Outlook for 2021 and Beyond. As displayed in the figure below, these six market drivers are projected to result in teleradiology reading service volumes increasing by 21% in 2021 and nearly doubling by 2025. Revenues for teleradiology reading service providers are forecast to follow a similar profile over this period.

Feature | Teleradiology | September 15, 2021 | By Arun Gill
The closely tied relationship between...
To get more flexibility and cost savings from storage, healthcare organizations are increasing their investments in the cloud
Feature | Information Technology | September 15, 2021 | By Kumar Goswami
Healthcare organizations today are storing petabytes of medical imaging data — lab slides,...